09:51 AM EST - Labopharm Inc. : announced that FDA has accepted its response for once-daily tramadol submitted on July 2, 2008, including the additional analysis of existing data as suggested by the Agency. The company noted that FDA has accepted its response as a complete, Class 2 response. The action date assigned by the FDA under the Prescription Drug User Fee Act is January 2, 2009. Labopharm Inc.
shares T.DDS are trading up 32 cents at $1.83.
